Early prenatal detection of triploidy: a 9-year experience in mainland China. (17th December 2021)

• Record Type: Journal Article
• Authors: Pan, Min; Yang, Dan; He, Yi; Han, Jin; Zhen, Li; Yang, Yan-Dong; Li, Dong-Zhi
• Is Part Of: Journal of maternal-fetal & neonatal medicine. Volume 34:Number 24(2021)
• Page Start: 4072
• Page End: 4076
• Publication Date: 2021-12-17
• Subjects: First trimester screening -- prenatal diagnosis -- triploidy -- ultrasound; Obstetrics -- Periodicals; Perinatology -- Periodicals; Infants (Newborn) -- Diseases -- Periodicals; Neonatology -- Periodicals; 618.2
• DOI: 10.1080/14767058.2019.1702963
• Languages: English
• ISSNs: 1476-7058

Abstract

Abstract: Objective: In this study, we report the indications for prenatal cytogenetic diagnosis of triploid cases, in an attempt to identify clues to early diagnosis. Study design: This was a retrospective analysis of prenatal cases of triploidy during a 9-year period at mainland China. Clinical data were reviewed for these cases, including maternal demographics, indications for invasive testing, fetal ultrasound findings, and pregnancy outcomes. Results: A total of 22 singleton pregnancies affected with triploid fetuses were detected. The fetal karyotype included 69, XXX (72.7%) and 69, XXY (27.3%). Eighteen cases were identified by the first trimester screening program. One case was missed by maternal cell-free DNA testing, but detected by second trimester anatomy scan. Three cases escaped the first trimester screening and were detected by second trimester anatomy scan. Conclusions: The present study demonstrates that most triploid cases can be diagnosed prenatally during the first trimester. The early asymmetrical fetal growth restriction, structural anomalies, and extremely high risk serum screening result for trisomy 21 or 18 should alert the physicians to the investigation of triploidy. Key Message: Ultrasound-based first-trimester screening plays a major role in early diagnosis of fetal triploidy. Future replacement of routine first-trimester screening by cell-DNA testing might miss the chance of early diagnosis and management of triploid pregnancies.